Globally acute, chronic, and traumatic wounds affect more than 500 million people. 280 million wound procedures are done annually pertaining to diabetic foot ulcers, venous ulcers, pressure ulcers, burn wounds and other SSTIs. Unfortunately, 70% of the wounds delay in healing due to infections and vascular issues. Current visual signs and symptoms to assess these parameters are only 57% percent accurate while the gold standard tests are cumbersome and expensive. Delayed wound healing causes more than 50 billion dollars in healthcare expenditure.

Illuminate®, a groundbreaking imaging device revolutionizing wound assessment. It non-invasively detects infection, analyses tissue in 2 minutes, and employs machine/deep learning to classify bacteria gram type. 100 times faster than traditional tests, Illuminate® aids in swift first-line treatment, enhances antibiotic stewardship, accelerates wound closure, and improves vascularization. This cost-effective, patented innovation is compact, offering a world-first solution for comprehensive wound assessment, particularly in low-resource settings.